Stockscreener 앱 받기
4.99
1.77%
-0.09
Olema Pharmaceuticals Inc 주식(OLMA)의 최신 뉴스
Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Olema's Breast Cancer Breakthrough Transform Patient Care? CEO Reveals Latest Data - StockTitan
Mehta named CMO, Greenberg CBO at Nura Bio - BioCentury
Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary - GlobeNewswire
Key Executive Hire: Biotech Veteran with 20-Year Track Record Joins Olema's C-Suite - StockTitan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Sees Large Decrease in Short Interest - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 5.4%Should You Sell? - MarketBeat
Olema Pharmaceuticals: Interesting But Undifferentiated Data (NASDAQ:OLMA) - Seeking Alpha
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Slashes -5.36%: What Could Be On The Way Going Forward? - Stocks Register
SG Americas Securities LLC Has $102,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
OLMA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Upward Trajectory: Olema Pharmaceuticals Inc (OLMA) Posts a Slidee, Closing at 5.69 - The Dwinnex
The Significance of Moving Averages in Olema Pharmaceuticals Inc Inc. (OLMA) Price Performance - The InvestChronicle
There is no way Olema Pharmaceuticals Inc (OLMA) can keep these numbers up - SETE News
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Olema Pharma's Strategic Talent Acquisition: $1.7M in Equity Grants Signals Growth Push - StockTitan
Olema Pharmaceuticals Inc (OLMA) Becoming More Attractive for Investors - Knox Daily
Are Olema Pharmaceuticals Inc (OLMA) shares a good deal now? - US Post News
Financial Metrics Exploration: Understanding Olema Pharmaceuticals Inc (OLMA) Through Ratios - The Dwinnex
Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Exclusive Access: Olema Pharmaceuticals Reveals Latest Oncology Progress at Two Elite Healthcare Forums - StockTitan
HR Positive/ HER2 Negative Breast Cancer Pipeline 2024: MOA - openPR
How To Trade (OLMA) - Stock Traders Daily
JPMorgan Chase & Co. Buys 157,171 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Purchases 157,171 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Holdings Increased by Hennion & Walsh Asset Management Inc. - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $27.00 Consensus Target Price from Brokerages - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Form 424B5 Olema Pharmaceuticals, - StreetInsider.com
Barclays PLC Purchases 48,614 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Bain Capital Life Sciences Investors, LLC Acquires Significant S - GuruFocus.com
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Major Shareholder Acquires $1,728,000.00 in Stock - MarketBeat
Bain Capital Life Sciences buys $1.7m in Olema Pharmaceuticals stock - Investing.com Nigeria
Olema Pharmaceuticals announces equity security exchange By Investing.com - Investing.com Australia
Olema Pharmaceuticals announces equity security exchange - Investing.com India
Olema Pharmaceuticals stock hits 52-week low at $5.02 - Investing.com India
Olema Pharmaceuticals stock hits 52-week low at $5.02 By Investing.com - Investing.com South Africa
(OLMA) Investment Report - Stock Traders Daily
Olema Pharmaceuticals Awards New Employee Stock Options for Cancer Drug Development Team - StockTitan
Olema Pharmaceuticals stock hits 52-week low at $5.55 By Investing.com - Investing.com Australia
0.27%
3.05%
자본화:
|
볼륨(24시간):